PopsiCube Opens Russian Affiliate
PopsiCube, the digital Clinical Research Organization, provides its pharmaceutical and health company sponsors with expertise in both clinical trial management and in digital services. This dual competency allows us to monitor phase I to IV clinical trials and develop innovative tools which are specific to the needs of our clients. In addition to providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry, PopsiCube is offering specific tailor made solutions and numerous applications in such fields as randomization, data capture, ePRO, eCOA, Patient Diary, biocaptors or data management, compliant with EMEA and FDA regulations and quality guidelines to facilitate the clinical development process. POPSICUBE is ISO 9001:2015 certified. In particular, we have developed an array of data capture solutions, from Digital Pen and Paper data capture, to eCRF, IVRS/IWRS and smartphone/tablet or biosensors solutions, allowing us to offer the technology that best matches the specificities of the clinical study protocol.
To be able to best support the growing demands of our worldwide customers, PopsiCube has decided to open a new affiliate in the Republic of Russia. The new company, PopsiCube Rus ooo, is based in Moscow. With this location, we also benefit from the presence of leading academic and research institutions in the Republic of Russia. It will allow us to support our growth objectives by establishing close relationships with our customers and by providing them with local, highly experienced management support for their projects.
“We are extremely excited by the creation of our Russian affiliate” commented Fabrice Beauchêne, PopsiCube Founder and Chairman, “Popsi Cube is experiencing a large growth (+62%) as the demand for our services and solutions is expanding rapidly within the health industry. We are committed to providing our sponsors with the highest level of service and we believe that proximity and internationalization is a critical element of our support. It will also allow us to more easily capitalize upon the large business opportunity represented by the Eurasian market.”
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
